Benzene, [[(2,2-dimethylpropyl)thio]methyl]- | 62266-24-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Benzene, [[(2,2-dimethylpropyl)thio]methyl]-
• 英文别名: 2,2-dimethylpropylsulfanylmethylbenzene
• CAS: 62266-24-4
• 化学式: C₁₂H₁₈S
• 分子量: 194.34
• InChiKey: QUCHCXWXQRQGIP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• SUBSTITUTED IMIDAZOLINE COMPOUNDS
  申请人：Merla Beatrix

  公开号：US20090048323A1

  公开（公告）日：2009-02-19

  Substituted imidazoline derivatives corresponding to Formula I: a method for producing them from substituted aldehyde compounds of Formula B: and the use of such imidazoline derivatives and aldehyde compounds to treat pain, depression, urinary incontinence, diarrhea, pruritus, alcohol and drug misuse, drug dependency, lethargy and/or anxiety.

  将对应于公式I的咪唑啉衍生物替代物：从公式B的替代醛化合物中生产它们的方法：以及使用这种咪唑啉衍生物和醛化合物来治疗疼痛、抑郁、尿失禁、腹泻、瘙痒、酒精和药物滥用、药物依赖、倦怠和/或焦虑。
• FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS
  申请人：Hangeland Jon J.

  公开号：US20090036438A1

  公开（公告）日：2009-02-05

  The present invention provides a method for treating a thrombotic or an inflammatory disorder administering to a patient in need thereof a therapeutically effective amount of at least one compound of Formula (I) or Formula (V): or a stereoisomer or pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, L, Z, R 3 , R 4 , R 6 , R 11 , X 1 , X 2 , and X 3 are as defined herein. The compounds of Formula (I) are useful as selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; for example thrombin, factor Xa, factor XIa, factor IXa, factor VIIa and/or plasma kallikrein. In particular, it relates to compounds that are selective factor XIa inhibitors. This invention also provides compounds within the scope of Formula I and relates to pharmaceutical compositions comprising these compounds.

  本发明提供了一种治疗血栓性或炎症性疾病的方法，该方法向需要治疗的患者施用至少一种公式（I）或公式（V）中的化合物的治疗有效量：或其立体异构体或药学上可接受的盐或溶剂形式，其中变量A、L、Z、R3、R4、R6、R11、X1、X2和X3如本文所定义。公式（I）的化合物可用作凝血级联和/或接触激活系统的丝氨酸蛋白酶酶的选择性抑制剂；例如凝血酶、因子Xa、因子XIa、因子IXa、因子VIIa和/或血浆激肽。特别是，涉及到选择性因子XIa抑制剂的化合物。本发明还提供了公式I范围内的化合物，并涉及包含这些化合物的制药组合物。
• SONIC HEDGEHOG MODULATORS
  申请人：Peng Lee F.

  公开号：US20110172233A1

  公开（公告）日：2011-07-14

  The present invention relates to relates to macrocyclic small molecule inhibitors of the Sonic Hedgehog signaling pathway, syntheses thereof, and intermediates thereto. Such small molecule modulators of the Sonic Hedgehog signaling pathway are useful in the treatment of proliferative diseases (e.g., basal cell carcinoma, Gorlin syndrome, medulloblastoma, or pancreatic cancer), pulmonary diseases (e.g., interstitial pnuemonitis or interstitial pulmonary fibrosis), and developmental disorders (e.g., phocomelia or cyclopia). Novel non-natural macrocycles are provided that inhibit Sonic Hedgehog induced-protein transcription.

  本发明涉及Sonic Hedgehog信号通路的大环小分子抑制剂、其合成和中间体。这种Sonic Hedgehog信号通路的小分子调节剂在治疗增殖性疾病（例如基底细胞癌、Gorlin综合症、髓母细胞瘤或胰腺癌）、肺部疾病（例如间质性肺炎或间质性肺纤维化）和发育障碍（例如肢体畸形或单眼畸形）中非常有用。提供了新型的非天然大环，可以抑制Sonic Hedgehog诱导的蛋白质转录。
• PROCESS FOR PRODUCING POLYDIENES
  申请人：Bridgestone Corporation

  公开号：EP2825574A1

  公开（公告）日：2015-01-21
• Process For Producing Polydienes
  申请人：Bridgestone Corporation

  公开号：US20150031845A1

  公开（公告）日：2015-01-29

  A method for producing a polydiene, the method comprising the steps of (i) forming an active catalyst by combining a lanthanide-containing compound, an alkylating agent, and a halogen source in the substantial absence of an organosulfide; and (ii) polymerizing conjugated diene monomer in the presence of the active catalyst and an organosulfide.